Dendreon Corp (NASDAQ:DNDN)

CAPS Rating: 1 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Recs

0
Player Avatar Orbantibor (< 20) Submitted: 4/28/2013 2:30:00 AM : Outperform Start Price: $3.98 DNDN Score: -15.79

The new tv ads turnus sales up, which crucial

Featured Broker Partners


Advertisement